Bilobol inhibits the lipopolysaccharide-induced expression and distribution of RhoA in HepG2 human hepatocellular carcinoma cells

  • Authors:
    • Jin Xu
    • Yueying Li
    • Xiaoming Yang
    • Yali Liu
    • Yongchang Chen
    • Min Chen
  • View Affiliations

  • Published online on: May 27, 2015     https://doi.org/10.3892/ol.2015.3276
  • Pages: 962-966
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Recent studies have revealed the localization of RhoA protein in the cell nucleus, in addition to its distribution in the cytosol and cell membrane. The results of previous studies by our group indicated that nuclear RhoA expression is increased, or RhoA is transported into the nucleus, when cells become cancerous or damaged. Furthermore, application of the anticancer agent Taxol appeared to reduce nuclear RhoA localization, indicating an association between the nuclear translocation of RhoA and tumor progression. Bilobol is a traditional Chinese medicine ingredient, however, its anticancer effect has remained unclear. The present study aimed to demonstrate the anticarcinogenic action of bilobol against hepatocellular carcinoma, in order to lay the foundations for subsequent research into the mechanisms underlying its anticancer effects. In the present study, HepG2 cells were treated with lipopolysaccharide (LPS), to induce inflammation, and/or bilobol. By performing an ELISA, it was observed that bilobol was able to suppress the inflammation induced by LPS. In addition, immunofluorescence and western blot analyses indicated that bilobol may reduce the expression of RhoA, suppress translocation of RhoA into the nucleus and inhibit the RhoA/Rho‑associated protein kinase signaling pathway. In conclusion, the present study revealed the potential anticancer effects of bilobol.
View Figures
View References

Related Articles

Journal Cover

August-2015
Volume 10 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu J, Li Y, Yang X, Liu Y, Chen Y and Chen M: Bilobol inhibits the lipopolysaccharide-induced expression and distribution of RhoA in HepG2 human hepatocellular carcinoma cells. Oncol Lett 10: 962-966, 2015
APA
Xu, J., Li, Y., Yang, X., Liu, Y., Chen, Y., & Chen, M. (2015). Bilobol inhibits the lipopolysaccharide-induced expression and distribution of RhoA in HepG2 human hepatocellular carcinoma cells. Oncology Letters, 10, 962-966. https://doi.org/10.3892/ol.2015.3276
MLA
Xu, J., Li, Y., Yang, X., Liu, Y., Chen, Y., Chen, M."Bilobol inhibits the lipopolysaccharide-induced expression and distribution of RhoA in HepG2 human hepatocellular carcinoma cells". Oncology Letters 10.2 (2015): 962-966.
Chicago
Xu, J., Li, Y., Yang, X., Liu, Y., Chen, Y., Chen, M."Bilobol inhibits the lipopolysaccharide-induced expression and distribution of RhoA in HepG2 human hepatocellular carcinoma cells". Oncology Letters 10, no. 2 (2015): 962-966. https://doi.org/10.3892/ol.2015.3276